Treatment Failure and Clinical Stability in Severe Community-Acquired Pneumonia

被引：0
|
作者：
Mendez, Raul [1 ,2 ,3 ,4 ]
Gonzalez-Jimenez, Paula [1 ,2 ,3 ]
Mengot, Noe [1 ,2 ]
Menendez, Rosario [1 ,2 ,3 ,4 ,5 ]
机构：
[1] La Fe Univ & Polytech Hosp, Pneumol Dept, Valencia, Spain
[2] Hlth Res Inst La Fe IISLAFE, Resp Infect, Valencia, Spain
[3] Univ Valencia, Dept Med, Valencia, Spain
[4] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Resp, Madrid, Spain
[5] Hosp Univ & Politecn La Fe, Serv Neumol, Avda Fernando Abril Martorell 106, Valencia 46026, Spain
来源：
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 45卷 / 02期
关键词：
CAP; inflammatory-immune response; microbiologic treatment; RESPIRATORY-DISTRESS-SYNDROME; INFECTIOUS-DISEASES-SOCIETY; LENGTH-OF-STAY; HOSPITALIZED-PATIENTS; ANTIBIOTIC-TREATMENT; THORACIC-SOCIETY; RISK-FACTORS; EARLY SWITCH; TIME; OUTCOMES;
D O I：
10.1055/s-0043-1778139
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
Treatment failure and clinical stability are important outcomes in community-acquired pneumonia (CAP). It is essential to know the causes and risk factors for treatment failure and delay in reaching clinical stability in CAP. The study of both as well as the associated underlying mechanisms and host response are key to improving outcomes in pneumonia.
引用
收藏
页码：225 / 236
页数：12
相关论文
共 50 条
  • [1] Clinical Stability versus Clinical Failure in Patients with Community-Acquired Pneumonia
    Aliberti, Stefano
    Blasi, Francesco
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 33 (03) : 284 - 291
  • [2] Treatment failure in community-acquired pneumonia
    Menendez, Rosario
    Torres, Antoni
    CHEST, 2007, 132 (04) : 1348 - 1355
  • [3] Corticosteroid treatment of severe community-acquired pneumonia
    Gorman, Sean K.
    Slavik, Richard S.
    Marin, Judith
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (7-8) : 1233 - 1237
  • [4] Optimal Treatment of Severe Community-Acquired Pneumonia
    Waterer, Grant W.
    Restrepo, Marcos I.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2007, 3 (03) : 233 - 239
  • [5] Corticosteroids in the Treatment of Severe Community-Acquired Pneumonia
    Tasha D. Ramsey
    Sean K. Gorman
    Current Infectious Disease Reports, 2014, 16
  • [6] Corticosteroids in the Treatment of Severe Community-Acquired Pneumonia
    Ramsey, Tasha D.
    Gorman, Sean K.
    CURRENT INFECTIOUS DISEASE REPORTS, 2014, 16 (05) : 1 - 7
  • [7] A comparison between time to clinical stability in community-acquired aspiration pneumonia and community-acquired pneumonia
    Jaoude, Philippe
    Badlam, Jessica
    Anandam, Anil
    El-Solh, Ali A.
    INTERNAL AND EMERGENCY MEDICINE, 2014, 9 (02) : 143 - 150
  • [8] Fluoroquinolones in the treatment of severe community-acquired pneumonia
    Wilcox, Mark H.
    Finch, Roger
    Wyncoll, Duncan
    Gould, Kate
    Howard, Philip
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2011, : S2 - S7
  • [9] A comparison between time to clinical stability in community-acquired aspiration pneumonia and community-acquired pneumonia
    Philippe Jaoude
    Jessica Badlam
    Anil Anandam
    Ali A. El-Solh
    Internal and Emergency Medicine, 2014, 9 : 143 - 150
  • [10] Prognostic factors for early clinical failure in patients with severe community-acquired pneumonia
    Hoogewerf, M.
    Oosterheert, J. J.
    Hak, E.
    Hoepelman, I. M.
    Bonten, M. J. M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (11) : 1097 - 1104
12345